Rejected at 2:02 a.m. Apr, 02, 2024 ] by herstein.jacob
Author: djmitche
Related Note: 1550761615191
Rationale for change

SGLT2 inhibitors and Entresto have been added to the list of mortality benefit medications in CHF
Source: AMBOSS - https://next.amboss.com/us/article/rS0faf?q=congestive+heart+failure#Z07d22fa4c3f9da63ddf39683e4eaa845

Rejection reason

card is being deleted (dupe of nid:1555286309380)

Text Text
Extra
- Angel in the back with heart failure balloon (decrease AT2 mediated remodeling)
- Carved stand with heart failure balloon (prevents remodeling by blocking catecholamines)
- Block aldosterone receptors in the heart, stopping remodeling
 
Duplicate card! If you have already unsuspended this card which is now marked for deletion, please use nid:1555286309380 as replacement. If you have not unsuspended this card, you can simply delete :)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#OME_banner::Clinical::01_Cardiology::02_Heart_Failure #AK_Step2_v12::#UWorld::2732 !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Internal-Medicine::1-OME #AK_Step2_v12::#B&B::02_Cardiology::03_Heart_Failure::01_02_Heart_Failure #AK_Step2_v12::#Subjects::Cardiology::03_Heart_Failure::Treatment #AK_Step3_v12::#OME::Intern_Content::Common_Medical_Problems::CHF_1:_In_the_Clinic #AK_Step2_v12::Original_decks::Dorian::im::ome::cardio::hf #AK_Step2_v12::Original_decks::Dorian::fam::nbme #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::03_Heart_Failure #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::!DELETE(Duplicate) #AK_Step2_v12::!Shelf::#Cards_AnKing_Skipped #AK_Step2_v12::#Resources_by_rotation::FM::nbme #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::hf #AK_Step2_v12::#B&B::02_Cardiology::05_Pharmacology::02_Cardiovascular_Pharmacology_II